Proto Labs, Inc. reported $561M of revenue over the trailing twelve months, +10% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $561M (to Q2 2026). Net income: $30M, trailing twelve months to Q2 2026. Free cash flow: $57M, trailing twelve months to Q2 2026. Operating margin: 6.5%, trailing twelve months to Q2 2026.

PRLBProto Labs, Inc.

Industrials

$93.72+85% 1Y

$93.72

$46.8152 weeks$98.70

PRLB as reported

Proto Labs, Inc. reported $561M of revenue over the trailing twelve months, +10% on the year before. 11 reported series are charted on this page, each one as filed.

$561M

Revenue, trailing twelve months · to Q2 2026 · +10% against the twelve months before

Net income: $30M
Net income · +106% year on year · trailing twelve months to Q2 2026
Free cash flow: $57M
Free cash flow · −14% year on year · trailing twelve months to Q2 2026
Operating margin: 6.5%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for PRLB, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$561M	+10%	Q2 2026
Net income	$30M	+106%	Q2 2026
EPS	$1.25	+105%	Q2 2026
Gross margin	45%	n/a	Q2 2026
Operating margin	6.5%	n/a	Q2 2026
Net margin	5.4%	n/a	Q2 2026
ROE	3.4%	n/a	Q2 2026
ROA	3.0%	n/a	Q2 2026
ROIC	24%	n/a	Q3 2015 · 43 quarters behind
Free cash flow	$57M	−14%	Q2 2026
P/E	75.0	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.